Q: Amgen beat on earnings and revenues, quite handily, and yet the stock is down 5% today. Personally, I think Amgen is a best-in-class biotech and will continue to be a long-term holder, but I would like your take on the market reaction.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Thoughts on earnings report?
Q: I hold LLY shares. Following the announcement of weight loss trial results, the stock declined approximately 14%, despite an improved 2025 outlook after a positive Q2 report. My current position is down 20%, and this investment makes up 5% of my portfolio.
Is this an appropriate time to consider increasing my position? Alternatively, are there other securities that you would prefer ? I would like to take advantage of the Trump turmoil. I am overweight technology.
Thank you kindly. Very appreciative of your comments.
Elaine
Is this an appropriate time to consider increasing my position? Alternatively, are there other securities that you would prefer ? I would like to take advantage of the Trump turmoil. I am overweight technology.
Thank you kindly. Very appreciative of your comments.
Elaine
Q: Can you comment on the drop in Eli Lilly? Is this stock worth holding, or are there better names in the sector? Thanks.
Q: Can you please explain the press releases by $oscr $cnc and others related to Medicare and the weak skate prices for these Healthcare companies? Is this weakness likely to last with the Trump policy changes? It's there value here or a longer lasting fundamental change to the revenue potential?
-
Intuitive Surgical Inc. (ISRG $457.78)
-
Eli Lilly and Company (LLY $963.33)
-
ResMed Inc. (RMD $205.02)
-
Medpace Holdings Inc. (MEDP $417.54)
-
The Ensign Group Inc. (ENSG $183.72)
Q: Hi,
With the purpose of investing in the health sector, which stocks would you consider now for best growth, either in the U.S or Canadian market, for the next 3 to 5 years ?
In addition, which are your high conviction stocks in the sector ?
Gratefully,
Jacques IDS
With the purpose of investing in the health sector, which stocks would you consider now for best growth, either in the U.S or Canadian market, for the next 3 to 5 years ?
In addition, which are your high conviction stocks in the sector ?
Gratefully,
Jacques IDS
Q: WELL has posted decent numbers in recent quarters yet the valuation continues to contract. This could of course set the stage for a strong rally. The market seems to have lost some confidence in the management of WELL. Has your opinion of management changed over the past few years based on company execution or missteps?
Thanks.
Thanks.
Q: Hi 5i,
Currently own both LLY & ISRG. They have become a smaller percentage of my portfolio over the past year and I am currently looking to consolidate by selling one to purchase the other.
From the perspective of a 5+ year hold, which stock do you believe to have the greatest growth potential from here?
Thank you.
Greg C.
Currently own both LLY & ISRG. They have become a smaller percentage of my portfolio over the past year and I am currently looking to consolidate by selling one to purchase the other.
From the perspective of a 5+ year hold, which stock do you believe to have the greatest growth potential from here?
Thank you.
Greg C.
Q: Thoughts on HIMS moving forward ? Are you still as bullish as before ?
Thanks
Thanks
Q: What are your thoughts on the class action securities lawsuits filed against NVO, and on class action securities lawsuits in general? Specifically related to NVO, I understand there are two lawsuits alleging that NVO misled investors, one linked to the ~18% stock price drop on December 20, 2024, and a more recent claim linked to the ~21% drop on July 29, 2025. What are the typical chances of receiving a recovery, what might the recovery amount be (% of losses), and how long do these lawsuits usually take to resolve? As an NVO shareholder, should I sign up for the more recent lawsuit, if eligible?
Q: Dead or not dead? I know it isn't your style but might there be a bounce opportunity for a few immediate dollars or is the story here so bad that it's going to drift and decline?
Q: Came across this small cap Pharmaceutical CO. from Victoria BC and would like your evaluation of them and your thoughts on a small position?
Thanx
Gary
Thanx
Gary
Q: This stock has been pretty volatile. Can you explain why. Is it worth keeping. Do you see any signs of growth in a year or so.
Q: I-MAB (IMAB:Nasdaq) is up 11% today on 4 times the usual volume. Is this a sign of a fundamentally significant move in its prospects? Your insight would be much appreciated as it is well-rated but not by firms/analysts I recognize.
Thanks
David
Thanks
David
Q: Why do you think Health Care stocks around the world seem to be down on a yearly basis? Is there anything other than a normal cycle shift?
Thank you
Paul
Thank you
Paul
Q: Can I please have your opinion on $PRCT? It is down since CEO is retiring.
Q: Hi, NVO is bleeding big time today. At what price do you think it is tempting to buy or start dipping in? Thanks
Q: Hey,
Thoughts on starting a position here? Seems to be good value.
Thanks.
Thoughts on starting a position here? Seems to be good value.
Thanks.
Q: I currently only own AMGN is the biotech/medical sector. I am considering re-entring NOVO after the hit it is taking. Would you recommend 'catching the falling knife', purchasing LLY which appears to be suffering in sympathy with NOVO or an alternate to these two?
With appreciation,
Ed
With appreciation,
Ed
Q: Your analysis of the results out today please. What else could go wrong here to drive the price even further down?